State Street SPDR S&P Biotech ETF
654 hedge funds and large institutions have $12.1B invested in State Street SPDR S&P Biotech ETF in 2020 Q4 according to their latest regulatory filings, with 138 funds opening new positions, 233 increasing their positions, 170 reducing their positions, and 33 closing their positions.
318% more first-time investments, than exits
New positions opened: 138 | Existing positions closed: 33
55% more funds holding in top 10
Funds holding in top 10: 11 → 17 (+6)
37% more repeat investments, than reductions
Existing positions increased: 233 | Existing positions reduced: 170
35% more capital invested
Capital invested by funds: $8.96B → $12.1B (+$3.1B)
18% more funds holding
Funds holding: 554 → 654 (+100)
5.19% more ownership
Funds ownership: 171.15% → 176.34% (+5.2%)
80% less call options, than puts
Call options by funds: $883M | Put options by funds: $4.34B
Top Buyers
Top Sellers
| 1 |
JP Morgan Chase
New York
|
-$1.23B |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
-$570M |
| 3 |
Citigroup
New York
|
-$249M |
| 4 |
Barclays
London,
United Kingdom
|
-$238M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$224M |
XBI Hedge Fund Activity: Q4 2020 in Review
654 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in State Street SPDR S&P Biotech ETF (XBI) for Q4 2020, worth a combined $12.1B — up 35% from $8.96B a quarter earlier.
Buyers outnumbered sellers: 138 funds opened new XBI positions and 33 closed out — a net gain of 105 holders — while 233 added to existing stakes and 170 trimmed.
The largest buyer was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, adding an estimated $1.54B. The largest seller was JP Morgan Chase, cutting an estimated $1.23B.
- 654 institutional investors held State Street SPDR S&P Biotech ETF (XBI) as of Q4 2020, up from 554 in Q3 2020.
- Funds reported $12.1B of State Street SPDR S&P Biotech ETF stock for Q4 2020, up 35% quarter-over-quarter.
- 138 funds opened new State Street SPDR S&P Biotech ETF positions in Q4 2020 and 33 closed out, a net change of +105 holders.
- The largest State Street SPDR S&P Biotech ETF buyer in Q4 2020 was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, an estimated $1.54B added.
- The largest State Street SPDR S&P Biotech ETF seller in Q4 2020 was JP Morgan Chase, an estimated $1.23B sold.
Based on aggregated 13F filings for Q4 2020.